LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

LLY

1,008.73

-1.37%↓

JNJ

242.5

-1.77%↓

ABBV

224.75

+0.24%↑

NVS

162.69

-0.47%↓

MRK

122.26

+0.39%↑

Search

McKesson Corp

Geschlossen

BrancheGesundheitswesen

947.38 1.17

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

932.31

Max

949.03

Schlüsselkennzahlen

By Trading Economics

Einkommen

40M

1.3B

Verkäufe

3B

106B

KGV

Branchendurchschnitt

26.954

110.024

Dividendenrendite

0.33

Gewinnspanne

1.177

Angestellte

43,000

EBITDA

374M

1.8B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+3.73% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.33%

2.26%

Nächstes Ergebnis

7. Mai 2026

Nächste Dividendenausschüttung

1. Apr. 2026

Nächstes Ex-Dividendendatum

2. März 2026

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

10B

115B

Vorheriger Eröffnungskurs

946.21

Vorheriger Schlusskurs

947.38

Nachrichtenstimmung

By Acuity

51%

49%

284 / 351 Ranking in Healthcare

Technischer Score

By Trading Central

Vertrauen

Strong Bearish Evidence

McKesson Corp Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

19. Feb. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

19. Feb. 2026, 23:47 UTC

Market Talk

Nikkei May Decline Amid Caution Over Potential U.S. Strike on Iran -- Market Talk

19. Feb. 2026, 23:39 UTC

Akquisitionen, Fusionen, Übernahmen

Swiss Re Corporate Solutions to Buy QBE Insurance's Global Trade Credit and Surety Business >SREN.EB

19. Feb. 2026, 23:38 UTC

Ergebnisse

Samsung Fire & Marine Insurance 2025 Net KRW2.020T Vs. Net KRW2.077T >000810.SE

19. Feb. 2026, 23:38 UTC

Ergebnisse

Samsung Fire & Marine Insurance 2025 Oper Pft KRW2.659T Vs. Pft KRW2.650T >000810.SE

19. Feb. 2026, 23:38 UTC

Ergebnisse

Samsung Fire & Marine Insurance 2025 Rev KRW24.779T Vs. KRW22.657T >000810.SE

19. Feb. 2026, 23:37 UTC

Market Talk

Gold Edges Lower on Possible Position Adjustment -- Market Talk

19. Feb. 2026, 23:34 UTC

Ergebnisse

Samsung Fire & Marine Insurance 4Q Net Profit Missed FactSet-Compiled Consensus

19. Feb. 2026, 23:34 UTC

Ergebnisse

Samsung Fire & Marine Insurance 4Q Net KRW234.38B Vs. Net KRW207.88B >000810.SE

19. Feb. 2026, 23:33 UTC

Ergebnisse

Samsung Fire & Marine Insurance 4Q Oper Pft KRW391.26B Vs. Pft KRW252.81B >000810.SE

19. Feb. 2026, 23:33 UTC

Ergebnisse

Samsung Fire & Marine Insurance 4Q Rev KRW6.083T Vs. KRW6.297T >000810.SE

19. Feb. 2026, 22:13 UTC

Market Talk

Goodman's Lack of Earnings Upgrade 'Largely Timing Related' -- Market Talk

19. Feb. 2026, 22:08 UTC

Ergebnisse

Fairfax Financial 4Q Rev $8.11B >FFH.T

19. Feb. 2026, 22:07 UTC

Ergebnisse

Eldorado Gold 4Q EPS $1.19 >ELD.T

19. Feb. 2026, 22:06 UTC

Ergebnisse

Centerra Gold: 2026 Consolidated Gold Production Expected 250,000 to 280,000 Ounces, Copper Production Expected 50M to 60M Pounds >CG.T

19. Feb. 2026, 22:05 UTC

Ergebnisse

Eldorado Gold 4Q Adj EPS 63c >ELD.T

19. Feb. 2026, 22:05 UTC

Ergebnisse

Eldorado Gold 4Q Rev $577.2M >ELD.T

19. Feb. 2026, 22:04 UTC

Ergebnisse

Eldorado Gold 4Q Gold Sales 126,923 Ounces >ELD.T

19. Feb. 2026, 22:04 UTC

Ergebnisse

Eldorado Gold 4Q Gold Production 123,416 Ounces >ELD.T

19. Feb. 2026, 21:50 UTC

Market Talk
Ergebnisse

Tech, Media & Telecom Roundup: Market Talk

19. Feb. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

19. Feb. 2026, 21:50 UTC

Market Talk

Financial Services Roundup: Market Talk

19. Feb. 2026, 21:43 UTC

Ergebnisse

St Barbara 1H Underlying Profit A$1.3 Million Vs A$48.1 Million Loss Year Earlier

19. Feb. 2026, 21:42 UTC

Akquisitionen, Fusionen, Übernahmen

Palo Alto Networks Announces Offer to Purchase Relating to CyberArk Software Ltd.'s 0.00% Convertible Senior Notes Due 2030

19. Feb. 2026, 21:42 UTC

Ergebnisse

St Barbara 1H Revenue A$128.8 Million, Up 32% On-Year

19. Feb. 2026, 21:41 UTC

Ergebnisse

Correct: St Barbara 1H Net Loss A$249,000

19. Feb. 2026, 21:40 UTC

Ergebnisse

St Barbara 1H Net Loss A$249 Million

19. Feb. 2026, 21:39 UTC

Ergebnisse

Perseus Mining Reaffirms FY26 Production, AISC Guidance

19. Feb. 2026, 21:37 UTC

Ergebnisse

These Stocks Are Today's Movers: Walmart, Occidental, Klarna, Wayfair, Deere, Omnicom, EPAM, and More -- Barrons.com

19. Feb. 2026, 21:37 UTC

Ergebnisse

Century Aluminum Expects 1Q Adj EBITDA $215 M to $235 M >CENX

Peer-Vergleich

Kursveränderung

McKesson Corp Prognose

Kursziel

By TipRanks

3.73% Vorteil

12-Monats-Prognose

Durchschnitt 982.27 USD  3.73%

Hoch 1,107 USD

Tief 885 USD

Basierend auf 11 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für McKesson Corp – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

11 ratings

9

Buy

2

Halten

0

Sell

Technischer Score

By Trading Central

681.92 / 707.28Unterstützung & Widerstand

Kurzfristig

Strong Bearish Evidence

Mittelfristig

No Evidence

Langfristig

No Evidence

Stimmung

By Acuity

284 / 351 Ranking in Gesundheitswesen

Nachrichtenstimmung

Bärische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Überdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über McKesson Corp

McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions (RxTS), Medical-Surgical Solutions, and International. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar and over-the-counter pharmaceutical drugs, and other healthcare-related products. This segment also offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and consulting, outsourcing, technological, and other services, as well as sells financial, operational, and clinical solutions to pharmacies. The RxTS segment serves biopharma and life sciences partners, and patients to address medication challenges for patients by working across healthcare; connects patients, pharmacies, providers, pharmacy benefit managers, health plans, and biopharma companies to deliver innovative solutions to help people get the medicine needed to live healthier lives; and provides prescription price transparency, benefit insight, dispensing support, third-party logistics, and wholesale distribution support services. The Medical-Surgical Solutions segment offers medical-surgical supply distribution, logistics, and other services to healthcare providers, including physician offices, surgery centers, nursing homes, hospital reference labs, and home health care agencies. The International segment provides distribution and services to wholesale, institutional, and retail customers in Europe and Canada. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.
help-icon Live chat